Stryker closes Amplitude Vascular acquisition

With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.

Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

Portage, Michigan, May 07, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK announced that it has completed the acquisition of Amplitude Vascular Systems, Inc. (AVS), a privately held medical technology ...
MassDevice

Stryker completes acquisition of Amplitude Vascular Systems

Stryker (NYSE:SYK) announced today that it completed its acquisition of Amplitude Vascular Systems (AVS) for an undisclosed ...
Yahoo Finance

Abbott gets FDA nod to begin IVL trial after rivals buy up competition

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MD&M East

FastWave Granted 6th Utility Patent for IVL Technology

FastWave Medical, a developer in advanced intravascular lithotripsy (IVL) technology, announced the issuance of its sixth utility patent by the United States Patent and Trademark Office (USPTO). This ...
Medscape

In Two Trials, Balloons Found As Good As IVL But Less Costly for Calcified Coronary Lesions

SAN FRANCISCO — Two different balloon devices developed for the treatment of calcified coronary lesions were found noninferior to intravascular lithotripsy (IVL) at a lower cost in separate major ...